| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Igc Pharma, Inc. (IGC) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. IGC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.99M | $1.08M | - | |
| Dir | 1.37M | $371.6K | - | |
| Other | 1.13M | $307.4K | - | |
| Dir | 500.0K | $135.5K | - | |
| Dir | 500.0K | $135.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2018 | Prins Richard K | Director | Sell | 50,000 | $1.08 | $54,000.00 | -12.0% | |
| Jan 12, 2018 | Mukunda Ram | Exec. Chairman &CEO | Sell | 36,000 | $1.09 | $39,161.55 | -0.3% | |
| Dec 15, 2017 | Mukunda Ram | Exec. Chairman &CEO | Sell | 50,000 | $0.76 | $37,750.00 | -1.0% | |
| Dec 8, 2017 | Mukunda Ram | Exec. Chairman &CEO | Sell | 154,950 | $0.86 | $132,908.50 | -0.8% | |
| Dec 4, 2017 | Prins Richard K | Director | Sell | 25,000 | $0.55 | $13,768.30 | -0.8% |